{"id":232376,"date":"2019-09-25T02:08:32","date_gmt":"2019-09-25T06:08:32","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=232376"},"modified":"2025-01-16T09:58:40","modified_gmt":"2025-01-16T14:58:40","slug":"blackberry-stock-dives-after-weak-q2-revenue-attributed-to-legacy-software-unit","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2019\/09\/25\/blackberry-stock-dives-after-weak-q2-revenue-attributed-to-legacy-software-unit\/","title":{"rendered":"BlackBerry stock dives after weak Q2 revenue attributed to legacy software unit"},"content":{"rendered":"<figure id=\"attachment_196909\" aria-describedby=\"caption-attachment-196909\" style=\"width: 640px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/01\/3023046280_c1d5319f93_z.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-196909\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/01\/3023046280_c1d5319f93_z.jpg\" alt=\"\" width=\"640\" height=\"428\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/01\/3023046280_c1d5319f93_z.jpg 640w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/01\/3023046280_c1d5319f93_z-300x201.jpg 300w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/01\/3023046280_c1d5319f93_z-20x13.jpg 20w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/a><figcaption id=\"caption-attachment-196909\" class=\"wp-caption-text\">Earlier Tuesday, BlackBerry, which keeps its books in U.<\/p>\n<div style=\"position:absolute;left:-99195px;\"> buy bupropion online <a href=\"https:\/\/udelldental.com\/img\/udell-dental\/png\/bupropion.html\">https:\/\/udelldental.com\/img\/udell-dental\/png\/bupropion.html<\/a> no prescription pharmacy <\/div>\n<p>S. dollars, reported revenue in what was BlackBerry&#8217;s second quarter grew to US$244 million under generally accepted accounting principles, up from $210 million in the same quarter last year. (<a href=\"https:\/\/www.flickr.com\/photos\/benstassen\/3023046280\/in\/photolist-5B8UkA-9QLYi8-SZAuHV-7Az8by-FZcnck-7AvmZH-9DAyES-FZc7dn-4WxCyv-24yxHRs-25Dkfzg-7GQf1v-336KDb-5t8TDm-25DkfMa-5qDbhc-4g4K15-7W5MfV-6YPGye-nwzFFd-6BsJEQ-9QPPEU-dzk7yC-3dU1TQ-akzJq7-9QPPCb-63MR6E-63MRaE-9QLYap-8rVUfw-8ireBs-6cabz5-4QnLCw-25DkfQX-7Dvioz-7vadXo\">File Photo<\/a>: <a href=\"https:\/\/www.flickr.com\/photos\/benstassen\/\">Ben Stassen\/Flickr<\/a>, <a href=\"https:\/\/creativecommons.org\/licenses\/by\/2.0\/\">CC BY 2.0<\/a>)<\/figcaption><\/figure>\n<p>TORONTO \u2014 BlackBerry Ltd. shares suffered their worst one-day loss of the year Tuesday after the company&#8217;s second-quarter revenue fell short of analyst estimates, blamed on difficulties in a legacy unit that sells software and services to businesses.<\/p>\n<p>The weak revenue was mainly confined to a segment that provides software to organizations that require secure communications, such as government agencies and financial services, executive chairman John Chen said.<\/p>\n<p>\u201cAll of our businesses performed at, or better than, our revenue expectations \u2014 except for enterprise software and services, or ESS,\u201d he said on a conference call with analysts.<\/p>\n<p>Chen said \u201cwe are all disappointed with the short-term results\u201d but added BlackBerry is strategically well positioned in the market for the internet of things and the automotive market.<\/p>\n<p>He said the weak sales at ESS were mainly due to \u201cexecution\u201d by a \u201cretooled\u201d sales team that didn&#8217;t perform well in closing deals.<\/p>\n<p>Chen provided analysts with an extensive list of individual personnel changes but the major transition announced Tuesday was the appointment of chief financial officer Steve Capelli to a new position, chief revenue officer.<\/p>\n<p>Capelli, who has been BlackBerry&#8217;s CFO since September 2016, will officially continue that role until Oct. 1. He&#8217;ll be succeeded as CFO at that time by Steve Rai, who has been deputy chief financial officer.<\/p>\n<p>Earlier Tuesday, BlackBerry, which keeps its books in U.S. dollars, reported revenue in what was BlackBerry&#8217;s second quarter grew to US$244 million under generally accepted accounting principles, up from $210 million in the same quarter last year.<\/p>\n<p>It also reported a loss of $44 million or eight cents per basic share for the quarter ended Aug. 31. That compared with an profit of $43 million or eight cents per share a year ago.<\/p>\n<p>Using its own non-GAAP metrics, which BlackBerry management and analysts refer to most often, revenue was $261 million and BlackBerry broke even on a per-share basis.<\/p>\n<p>Analysts on average had expected the company to break even with $266 million of adjusted revenue, according to financial markets data firm Refinitiv.<\/p>\n<p>BlackBerry shares closed down $2.25, or 22.7 per cent, at C$7.68 on the Toronto Stock Exchange and down .<\/p>\n<div style=\"position:absolute;left:-99195px;\"> buy cytotec online <a href=\"https:\/\/www.northwestphysicians.com\/wp-content\/uploads\/2025\/01\/png\/cytotec.html\">https:\/\/www.northwestphysicians.com\/wp-content\/uploads\/2025\/01\/png\/cytotec.html<\/a> no prescription pharmacy <\/div>\n<p>70, or 22.6 per cent at US$5.81 at the New York Stock Exchange, which handles a majority of trading in the company&#8217;s stock.<\/p>\n<p>This report by The Canadian Press was first published Sept.<\/p>\n<div style=\"position:absolute;left:-99195px;\"> buy xenical online <a href=\"https:\/\/www.northwestphysicians.com\/wp-content\/uploads\/2025\/01\/png\/xenical.html\">https:\/\/www.northwestphysicians.com\/wp-content\/uploads\/2025\/01\/png\/xenical.html<\/a> no prescription pharmacy <\/div>\n<p> 24, 2019.<\/p>\n<p>Companies in this story: (TSX:BB)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>TORONTO \u2014 BlackBerry Ltd. shares suffered their worst one-day loss of the year Tuesday after the company&#8217;s second-quarter revenue fell &hellip;<\/p>\n","protected":false},"author":44,"featured_media":196909,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-232376","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","mauthors-david-paddon","mauthors-the-canadian-press"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/232376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=232376"}],"version-history":[{"count":2,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/232376\/revisions"}],"predecessor-version":[{"id":284550,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/232376\/revisions\/284550"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/196909"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=232376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=232376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=232376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}